Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel gold-catalyzed cyclization method offers mild conditions and high yields for furan derivatives, ensuring reliable supply chain stability.
Discover the novel 6-step preparation method for CDK4/6 inhibitor SHR6390. Enhanced yield, mild conditions, and scalable process for high-purity pharmaceutical intermediates.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN111978265B reveals a robust FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel photocatalytic route for dihydronaphthalene derivatives offering mild conditions and high yields for pharmaceutical intermediates.
Patent CN113046772A details a metal-free electrochemical route for 4-selenopyrazoles, offering high purity and scalability for pharmaceutical intermediates.
Patent CN115260188B reveals a cost-effective cobalt-catalyzed carbonylation route for tetrahydro-beta-carbolinones, offering significant supply chain and purity advantages for pharmaceutical manufacturing.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Patent CN107556269B reveals a green, mild route for alpha-alkynyl ethers. This method offers significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed radical tandem cyclization offers mild conditions and high yields for fluorinated heterocycles, ensuring reliable supply chain stability.
Novel Pd-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN107216307A details a mild copper-catalyzed benzylic C-H arylation method, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108069835A reveals photocatalytic route for chiral helicenes. Offers cost reduction and supply chain reliability for asymmetric catalysis intermediates.
Patent CN120247882B reveals mild synthesis for antitumor compounds. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel boric porphyrin catalyzed route for avanafil offers high purity and green manufacturing advantages for reliable API intermediate suppliers.
Patent CN114276244B reveals mild synthesis for carboxylic acids. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN118126005B details metal-free synthesis of fluorinated heterocycles. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113666862A details a novel nickel-catalyzed asymmetric nitration for chiral 3-nitroindoles, offering superior stereoselectivity and cost efficiency for pharmaceutical intermediates.
Novel copper-catalyzed ring-opening method for high-yield synthesis of chiral and achiral biaryl halides. Reduces cost and improves scalability for API intermediates.
Patent CN114133389B details a one-pot synthesis of isoindolin-1-one fused rings, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.